Clene (CLNN) Accounts Payables (2019 - 2026)
Clene (CLNN) posted Accounts Payables of $1.1 million for Q2 2026, up 28.03% on a QoQ basis from $892000.0 in Q4 2025, and up 37.92% year-over-year from $828000.0 in Q2 2025.
Analysis
Clene (CLNN) Accounts Payables (2019 - 2026) Analysis & Trends
Clene has reported Accounts Payables for 8 years, with the latest figure at $1.1 million in Q2 2026.
- On a quarterly basis, Accounts Payables rose 37.92% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 37.92% increase from a year earlier, with the FY2025 full-year figure at $892000.0, down 28.06% from the prior year.
- Accounts Payables was $1.1 million for Q2 2026 at Clene, up from $892000.0 in the prior quarter.
- The five-year high for Accounts Payables was $4.5 million in Q2 2022, with the low at $608000.0 in Q1 2023.
- Average Accounts Payables over 5 years is $1.8 million, with a median of $1.4 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables surged 295.98% in 2022, then slumped 81.65% in 2023.
- Over 5 years, Accounts Payables stood at $3.0 million in 2022, then sank by 50.1% to $1.5 million in 2023, then retreated by 17.55% to $1.2 million in 2024, then fell by 28.06% to $892000.0 in 2025, then gained by 28.03% to $1.1 million in 2026.
- The last three Accounts Payables figures came in at $1.1 million (Q2 2026), $892000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 4.58 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 88.42 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 1.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Dec 31, 2025 | 892,000.00 |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 828,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.89 Mn |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 608,000.00 |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 3.45 Mn |
| Jun 30, 2022 | 4.53 Mn |
| Mar 31, 2022 | 3.31 Mn |
| Dec 31, 2021 | 1.92 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.14 Mn |